This HTML5 document contains 52 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1006/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n12https://w3id.org/oc/corpus/br/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q63199171
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в грудні 2002 scientific article published on 01 December 2002 wetenschappelijk artikel im Dezember 2002 veröffentlichter wissenschaftlicher Artikel مقالة علمية تنشرت ف 1 دجنبر 2002 artículu científicu espublizáu n'avientu de 2002
p:P577
wds:Q63199171-E539604F-4083-4884-8AFF-89C2DEB16EBB
wdt:P577
2002-12-01T00:00:00Z
p:P407
wds:Q63199171-D8738908-E1DB-4FD8-9A3D-F9E924965D6A
wdt:P407
wd:Q1860
p:P2093
wds:Q63199171-45C5DA0A-DCF0-4C98-AE34-9078F88F8B2B wds:Q63199171-73D23514-B5FD-4712-AD8A-8882A2244806 wds:Q63199171-6F7CD4E7-3D87-4E94-9089-FE7691157F8D wds:Q63199171-94203A9F-66BC-4BF7-B8E5-5182C2F30B38 wds:Q63199171-1DFDA185-6307-4404-8798-AE15830E85CE
p:P3181
wds:Q63199171-4A6B6414-541F-4F4E-9BD8-820747E65D27
wdtn:P3181
n12:338
wdt:P2093
David G Mutch Jeffrey M Fowler Neil S Horowitz Tom Manolitsas Seok Mo Kim
wdt:P3181
338
rdfs:label
Should the Presence of Lymphvascular Space Involvement Be Used to Assign Patients to Adjuvant Therapy Following Hysterectomy for Unstaged Endometrial Cancer? Should the Presence of Lymphvascular Space Involvement Be Used to Assign Patients to Adjuvant Therapy Following Hysterectomy for Unstaged Endometrial Cancer?
skos:prefLabel
Should the Presence of Lymphvascular Space Involvement Be Used to Assign Patients to Adjuvant Therapy Following Hysterectomy for Unstaged Endometrial Cancer? Should the Presence of Lymphvascular Space Involvement Be Used to Assign Patients to Adjuvant Therapy Following Hysterectomy for Unstaged Endometrial Cancer?
schema:name
Should the Presence of Lymphvascular Space Involvement Be Used to Assign Patients to Adjuvant Therapy Following Hysterectomy for Unstaged Endometrial Cancer? Should the Presence of Lymphvascular Space Involvement Be Used to Assign Patients to Adjuvant Therapy Following Hysterectomy for Unstaged Endometrial Cancer?
p:P50
wds:Q63199171-6BE47FE0-B9F9-4948-BA88-6E64A4E6120E
wdt:P50
wd:Q39381089
p:P1476
wds:Q63199171-82DE917D-CE73-490F-BF05-78070C7A1F2E
wdt:P1476
Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer?
p:P304
wds:Q63199171-30FFE7FF-3F8D-4AEF-8A89-F38FB34A79A6
wdt:P304
243-246
p:P31
wds:Q63199171-51F5EAF3-CDB0-4330-B0DF-2873DAB753B5
wdt:P31
wd:Q13442814
p:P921
wds:Q63199171-D2BA7279-D6D8-47D4-8AF6-BACAF1AA90A0
wdt:P921
wd:Q550675
p:P698
wds:Q63199171-D3BBCC55-85A2-4EBC-8D22-99487DDEFDF5
wdtn:P698
n13:12468320
wdt:P698
12468320
p:P1433
wds:Q63199171-136CE541-BD18-4ACF-AD90-AC5A1EE46218
wdt:P1433
wd:Q5625182
p:P433
wds:Q63199171-ADF70645-F784-4C00-973A-74EAD40A8FD9
p:P478
wds:Q63199171-B9456FE7-E5BD-4810-91B6-63120A159F57
wdt:P433
3
wdt:P478
87
p:P356
wds:Q63199171-04AD1F61-10D1-4B03-AB5D-12B2547DB50C
wdtn:P356
n10:GYNO.2002.6825
wdt:P356
10.1006/GYNO.2002.6825